Charles River Laboratories International (CRL) EBT Margin (2009 - 2025)

Charles River Laboratories International's EBT Margin history runs 17 years deep, the most recent figure standing at 29.58% for Q4 2025.

• In Q4 2025, EBT Margin fell 796.0% year-over-year to 29.58%; the TTM figure through Dec 2025 stood at 2.48% (down 478.0% YoY), while the FY2025 annual figure was 2.48%, down 478.0% from the prior year.
• EBT Margin for Q4 2025 stood at 29.58%, down from 8.68% in the prior quarter.
• The five-year high for EBT Margin was 22.27% in Q4 2022, with the low at 29.58% in Q4 2025.
• The 5-year median for EBT Margin is 11.89% (2022), against an average of 8.52%.
• The sharpest annual moves came in 2022 and 2024: EBT Margin soared 419 bps in 2022, then sank 4222 bps in 2024.
• Charles River Laboratories International's EBT Margin stood at 18.08% in 2021, then rose by 23 bps to 22.27% in 2022, then dropped by 8 bps to 20.59% in 2023, then plunged by 205 bps to 21.62% in 2024, then plunged by 37 bps to 29.58% in 2025.
• Business Quant data shows CRL's EBT Margin at 29.58% in Q4 2025, 8.68% in Q3 2025, and 6.92% in Q2 2025.